Back to search

Article

Antisense oligonucleotide therapeutics targeting age-related diseases

2025-09-16

Abstract excerpt

The rapid growth in the global aging population has intensified concerns regarding age-related diseases (ARDs), which pose substantial health and socioeconomic burdens. Current therapeutic strategies, such as small-molecule drugs, primarily target downstream pathophysiological manifestations, including inflammation, fibrosis, and metabolic imbalance, but have limited ability to address the underlying molecular cau...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
1d116636-aa92-55ec-a1dc-8af3c1e23f0f
DOI
10.22541/au.175804297.77156237/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Antisense oligonucleotide therapeutics targeting age-related diseasesDOI 10.22541/au.175804297.77156237/v1
Oligonucleotide Therapeutics for Age-Related Musculoskeletal Disorders: Successes and ChallengesSemantic proximity
Antisense Oligonucleotides: Technological Advances, Clinical Progress, and Expanding Therapeutic FrontiersSemantic proximity
The Versatile Applications of Antisense Oligonucleotides in Modern MedicineSemantic proximity
Therapeutic antisense oligonucleotides for movement disordersSemantic proximity
Age reprogramming: Innovations and ethical considerations for prolonged longevity (Review)Semantic proximity
Antisense Oligonucleotides: Treatment Strategies and Cellular InternalizationSemantic proximity
Antisense Oligonucleotide Therapy for the Nervous System: From Bench to Bedside with Emphasis on Pediatric NeurologySemantic proximity
Recent advances in antisense oligonucleotide therapy in genetic neuromuscular diseasesSemantic proximity
Clinical Applications of Single-Stranded Oligonucleotides: Current Landscape of Approved and In-Development TherapeuticsSemantic proximity
Antisense Oligonucleotide-Based Therapy for Neuromuscular DiseaseSemantic proximity
Therapeutic Antiaging StrategiesSemantic proximity
The expanding application of antisense oligonucleotides to neurodegenerative diseasesSemantic proximity
Select a neighboring publication to make it the new centre.